2017
DOI: 10.1016/j.yexcr.2017.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
40
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 64 publications
(43 citation statements)
references
References 24 publications
0
40
0
Order By: Relevance
“…Finally, we determined whether the miR-590-5p/YAP1 axis is correlated with chemotherapy response in HCC patients. For this experiment, needle tumor tissues obtained from 20 HCC patients with transarterial chemoembolization (TACE) were analyzed [ 28 ]. As shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Finally, we determined whether the miR-590-5p/YAP1 axis is correlated with chemotherapy response in HCC patients. For this experiment, needle tumor tissues obtained from 20 HCC patients with transarterial chemoembolization (TACE) were analyzed [ 28 ]. As shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The 20 patients received transarterial chemoembolization (TACE) in our hospital were enrolled and needle tissue samples were collected as reported previously [ 28 ]. All the process was performed in accordance with guidelines and regulations approved by the Fifth Affiliated Hospital of Wenzhou Medical University.…”
Section: Methodsmentioning
confidence: 99%
“…The high production of IL-6 and CCL5 in MAA-infected mice is most likely responsible for this accumulation. Both cytokines have been shown to induce proliferation of MDSC in tumors ( 48 , 49 ).…”
Section: Discussionmentioning
confidence: 99%
“…[44][45][46][47][48][49][50][51][52]. These evidence suggest that MDSCs contribute to the immunosuppressive network through multiple mechanisms and are potential immunotherapy targets for HCC.MDSCs from HCC patients are unable to stimulate an allogeneic T-cell response, suppress T-cell proliferation, and have high arginase activity.…”
mentioning
confidence: 98%